Steven Mizell, Merck's EVP and CHRO, shares how the company advanced its human resources function a…

Moderna, the almost 11 year old company that created a 95% effective pandemic ending vaccine in les…

Welcome to Dispensed. Inside, how startups are raising money amid the pandemic, and what to watch i…

"Now we are an oncology company," Moderna CEO Stéphane Bancel told Insider.

The men, who texted and emailed hundreds of companies, didn't expect to have 700 corporations, nonp…

Merck's positive drug data helped turn around US futures this morning even as core inflation saw it…

Kenneth Frazier, who has led the US pharma giant Merck for nearly 30 years, is retiring, and will b…

US stocks still closed the week lower on Friday, but well off the lows sparked by higher interest r…

As per World Health Organization estimates, India has around one-fifth of the global cervical cance…

Merck initially invested $50 million in Moderna before it was public in 2015, and subsequently inve…

"If we could buy a group of leading pharmaceutical companies at a below-market multiple, I think we…

The "Buffett Effect" kicked in after the famed investor disclosed about $6 billion in new pharmaceu…

The famed investor's company disclosed more than $1.8 billion worth of stock in each of AbbVie, Mer…

Washington Post CIO Shailesh Prakash is in the fortunate position to get to work closely with Jeff …

An expert panel of the country's central drug authority has recommended granting emergency use auth…

The antiviral drug could put a dent into the uptake of COVID-19 vaccines, as countries still strugg…

Pfizer plans to seek the Food and Drug Administration's OK this month for the pill, with doses pote…

If authorized, the drug, called molnupiravir, would become the first oral antiviral treatment for C…

Swift ectopic pregnancy treatment saves moms' lives. Even pro-life doctors say "there is no chance …

Announcing 3 deals on Tuesday, Merck unveiled its top research efforts for a coronavirus vaccine as…